Assort Health Raises $120 Million Series C at $1.2 Billion Valuation for AI Patient Scheduling Agents

Assort Health turning voice AI scheduling into a unicorn shows how much unglamorous administrative friction in healthcare, like phone-based appointment booking, is worth automating at scale. With 190 million patient voice interactions already logged and 15,000 physicians on the platform, this is one of the more commercially proven agentic AI deployments rather than a speculative bet. The jump to a 1.2 billion dollar valuation in a Series C led by Menlo Ventures signals investors increasingly reward AI products with measurable operational lift over ones chasing general purpose hype.